Brokerages Set Enovix Corporation (NASDAQ:ENVX) PT at $12.64

Enovix Corporation (NASDAQ:ENVX) has been given a consensus rating of “Moderate Buy” by the ten analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $12.6364.

Several analysts recently commented on ENVX shares. Wells Fargo & Company set a $6.00 target price on Enovix in a report on Thursday, March 12th. Bank of America started coverage on Enovix in a report on Thursday, March 12th. They set a “neutral” rating and a $6.00 target price on the stock. Craig Hallum dropped their target price on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Benchmark dropped their target price on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Finally, B. Riley Financial dropped their target price on Enovix from $17.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 2nd.

Enovix Stock Down 0.6%

Enovix stock opened at $6.66 on Wednesday. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. The business’s 50-day simple moving average is $6.67 and its two-hundred day simple moving average is $6.76. The company has a market cap of $1.45 billion, a PE ratio of -8.02 and a beta of 2.27. Enovix has a fifty-two week low of $4.61 and a fifty-two week high of $16.49.

Enovix (NASDAQ:ENVX) last posted its earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.01. The firm had revenue of $7.60 million for the quarter, compared to analyst estimates of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.Enovix’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same period last year, the company earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Equities analysts anticipate that Enovix will post -0.79 EPS for the current year.

Institutional Trading of Enovix

Several hedge funds and other institutional investors have recently bought and sold shares of ENVX. Caitlin John LLC acquired a new stake in Enovix during the third quarter worth about $27,000. Caitong International Asset Management Co. Ltd purchased a new position in Enovix during the fourth quarter worth approximately $30,000. Parallel Advisors LLC boosted its position in Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares in the last quarter. CWM LLC boosted its position in Enovix by 95.4% during the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after purchasing an additional 2,969 shares in the last quarter. Finally, Calamos Advisors LLC purchased a new position in Enovix during the first quarter worth approximately $60,000. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.